A 33-year-old woman comes to the physician because of a 3-day history of dry cough and low-grade fever. Four months ago, she was diagnosed with major depressive disorder and staed treatment with fluoxetine. Physical examination shows no abnormalities. A diagnosis of upper respiratory infection is made and medication is prescribed to relieve her symptoms. A drug with which of the following mechanisms of action should be avoided in this patient?

**Core Concept:**
The question is asking about the mechanism of action of a drug to be avoided in a patient with a history of major depressive disorder (MDD) being treated with fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of MDD by increasing the level of serotonin in the brain.

**Why the Correct Answer is Right:**
In this case, the correct answer is option **D** because fluoxetine is an SSRI that works by inhibiting the reuptake of serotonin, thereby increasing its concentration in the synaptic cleft and improving mood in patients with MDD. However, this drug may exacerbate the symptoms of upper respiratory infections due to its anticholinergic properties. Anticholinergic drugs can interfere with the body's natural response to infections, such as increasing mucus production and decreasing respiratory secretions, which can lead to more severe illness.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Antipsychotics)**: Antipsychotic drugs mainly affect dopamine and serotonin neurotransmission, not specifically serotonin like fluoxetine. While they might have anticholinergic effects, they are not as significant as fluoxetine's.

B. **Option B (Anti-anxiety medications)**: Anxiolytic drugs primarily target the GABA system, not serotonin. Although they may have anticholinergic effects, they are less potent than fluoxetine.

C. **Option C (Anti-epileptic medications)**: Antiepileptic drugs primarily affect neurotransmitter systems involved in seizure control, such as GABA and glutamate, rather than targeting serotonin. Although they may have anticholinergic effects, the focus is on their primary action.

**Clinical Pearl:**
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that can exacerbate upper respiratory infections due to its anticholinergic properties. In this case, it is crucial to choose a different medication to treat the patient's symptoms, as fluoxetine could potentially worsen the patient's condition. Always consider the specific mechanism of action of medications when selecting treatment options for patients with co-existing conditions, such as in this scenario where the patient has a concurrent upper respiratory infection.

✓ Correct Answer: A. Inhibition of NMDA glutamate receptors